| Dr Elizabeth Jane Saladin, MD | |
|
15951 Little Axe Dr, Norman, OK 73026-9088 | |
| (405) 447-0300 | |
| (405) 701-7963 |
| Full Name | Dr Elizabeth Jane Saladin |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 15951 Little Axe Dr, Norman, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326350752 | NPI | - | NPPES |
| 200476440B | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 33046 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Absentee Shawnee Tribal Health Authority, Inc | 5799171088 | 61 |
News Archive
On their way to Washington last week, Tea Party activists stopped in Lansing, Michigan. And among the officials who addressed them was Mike Cox, the state's Republican attorney general.
The American College of Physicians (ACP) today applauded CMS for making substantial improvements in its long- awaited Final Rule on Accountable Care Organizations.
The American Clinical Laboratory Association's Results for Life Campaign today applauded the American Diabetes Association for its decision to recommend the hemoglobin A1C laboratory test as a means of diagnosing diabetes and identifying pre-diabetes.
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
› Verified 1 days ago
| Entity Name | Absentee Shawnee Tribe Of Oklahoma |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942253521 PECOS PAC ID: 9335053479 Enrollment ID: O20031113000654 |
News Archive
On their way to Washington last week, Tea Party activists stopped in Lansing, Michigan. And among the officials who addressed them was Mike Cox, the state's Republican attorney general.
The American College of Physicians (ACP) today applauded CMS for making substantial improvements in its long- awaited Final Rule on Accountable Care Organizations.
The American Clinical Laboratory Association's Results for Life Campaign today applauded the American Diabetes Association for its decision to recommend the hemoglobin A1C laboratory test as a means of diagnosing diabetes and identifying pre-diabetes.
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
› Verified 1 days ago
| Entity Name | Li-si-wi-nwi Health, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124152962 PECOS PAC ID: 4183895519 Enrollment ID: O20130227000474 |
News Archive
On their way to Washington last week, Tea Party activists stopped in Lansing, Michigan. And among the officials who addressed them was Mike Cox, the state's Republican attorney general.
The American College of Physicians (ACP) today applauded CMS for making substantial improvements in its long- awaited Final Rule on Accountable Care Organizations.
The American Clinical Laboratory Association's Results for Life Campaign today applauded the American Diabetes Association for its decision to recommend the hemoglobin A1C laboratory test as a means of diagnosing diabetes and identifying pre-diabetes.
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
› Verified 1 days ago
| Entity Name | Absentee Shawnee Tribal Health Authority, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942253521 PECOS PAC ID: 5799171088 Enrollment ID: O20220414000294 |
News Archive
On their way to Washington last week, Tea Party activists stopped in Lansing, Michigan. And among the officials who addressed them was Mike Cox, the state's Republican attorney general.
The American College of Physicians (ACP) today applauded CMS for making substantial improvements in its long- awaited Final Rule on Accountable Care Organizations.
The American Clinical Laboratory Association's Results for Life Campaign today applauded the American Diabetes Association for its decision to recommend the hemoglobin A1C laboratory test as a means of diagnosing diabetes and identifying pre-diabetes.
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Jane Saladin, MD 15951 Little Axe Dr, Norman, OK 73026-9088 Ph: (405) 447-0300 | Dr Elizabeth Jane Saladin, MD 15951 Little Axe Dr, Norman, OK 73026-9088 Ph: (405) 447-0300 |
News Archive
On their way to Washington last week, Tea Party activists stopped in Lansing, Michigan. And among the officials who addressed them was Mike Cox, the state's Republican attorney general.
The American College of Physicians (ACP) today applauded CMS for making substantial improvements in its long- awaited Final Rule on Accountable Care Organizations.
The American Clinical Laboratory Association's Results for Life Campaign today applauded the American Diabetes Association for its decision to recommend the hemoglobin A1C laboratory test as a means of diagnosing diabetes and identifying pre-diabetes.
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
› Verified 1 days ago
Ms. Kathleen E Lewis, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1300 Mcgee Dr, Ste 100, Norman, OK 73072 Phone: 405-321-0406 Fax: 405-447-6293 | |
Jayson D Henry, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 E Robinson St, Suite 2200, Norman, OK 73071 Phone: 405-515-0380 Fax: 405-928-2054 | |
Dr. Hieu Chi Nguyen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 24th Ave Nw, Norman, OK 73069 Phone: 405-364-0555 Fax: 405-573-5464 | |
Kevin Q Epperson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 W Tecumseh Rd, Suite 104, Norman, OK 73072 Phone: 405-515-1800 Fax: 405-515-1805 | |
Bobby L Elliott, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 24th Ave Nw, Norman, OK 73069 Phone: 405-573-5400 Fax: 405-573-5406 | |
Dr. Aaron Michael Smathers, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 W Tecumseh Rd Ste 101, Norman, OK 73072 Phone: 405-515-0649 Fax: 405-360-6769 | |
Michelle Deann Barnes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 N Porter Ave, Suite 300, Norman, OK 73071 Phone: 405-329-0121 Fax: 405-292-6099 |